Evidence map›Paper›PMID 26055384›Full record

ArticleAntimicrobial agents and chemotherapy2015

Characterization of BKC-1 class A carbapenemase from Klebsiella pneumoniae clinical isolates in Brazil.

Adriana Giannini Nicoletti, Marcelo F M Marcondes, Willames M B S Martins, Luiz G P Almeida, Marisa F Nicolás, Ana T R Vasconcelos, Vitor Oliveira, Ana Cristina Gales

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 84 citations in OpenAlex.

  1. Detection of virulent Klebsiella pneumoniae strains causing intestinal and extraintestinal infections during the 80s and 90s in Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  2. Emergence of multidrug-resistantOne health (Amsterdam, Netherlands) · 2024
    Article
  3. Microbiology spectrum · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The biogenesis of β-lactamase enzymes.Microbiology (Reading, England) · 2022
    Review
  9. Article
  10. Role of ISAntimicrobial agents and chemotherapy · 2022
    Article
  11. Article
  12. Article
  13. Frequency and Diversity of HybridMicroorganisms · 2021
    Article
  14. Article
  15. Extensively drug-resistant IMP-16-producing Pseudomonas monteilii isolated from cerebrospinal fluid.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Article
  16. Article
  17. Article
  18. Biochemical Activity of Vaborbactam.Antimicrobial agents and chemotherapy · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Adriana Giannini NicolettiLaboratório Alerta, Disciplina de Infectologia, Departamento de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil adrianagn@gmail.com.
Marcelo F M MarcondesLaboratório de Enzimologia, Departamento de Biofísica, Universidade Federal de São Paulo, São Paulo, Brazil.
Willames M B S MartinsLaboratório Alerta, Disciplina de Infectologia, Departamento de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Luiz G P AlmeidaLaboratório Nacional de Computação Científica, Petrópolis, Brazil.
Marisa F NicolásLaboratório Nacional de Computação Científica, Petrópolis, Brazil.
Ana T R VasconcelosLaboratório Nacional de Computação Científica, Petrópolis, Brazil.
Vitor OliveiraLaboratório de Enzimologia, Departamento de Biofísica, Universidade Federal de São Paulo, São Paulo, Brazil.
Ana Cristina GalesLaboratório Alerta, Disciplina de Infectologia, Departamento de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Universidade Federal de São Paulo · BRLaboratório Nacional de Computação Científica · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three Klebsiella pneumoniae clinical isolates demonstrating carbapenem resistance were recovered from different patients hospitalized at two medical centers in São Paulo, Brazil. Resistance to all β-lactams, quinolones, and some aminoglycosides was observed for these isolates that were susceptible to polymyxin B. Carbapenem hydrolysis, which was inhibited by clavulanic acid, was observed for all K. pneumoniae isolates that belonged to the same pulsed-field gel electrophoresis (PFGE) type and a novel sequence type (ST), ST1781 (clonal complex 442 [CC442]). A 10-kb nonconjugative incompatibility group Q (IncQ) plasmid, denominated p60136, was transferred to Escherichia coli strain TOP10 cells by electroporation. The full sequencing of p60136 showed that it was composed of a mobilization system, ISKpn23, the phosphotransferase aph3A-VI, and a 941-bp open reading frame (ORF) that codified a 313-amino acid protein. This ORF was named bla BKC-1. Brazilian Klebsiella carbapenemase-1 (BKC-1) showed a pI of 6.0 and possessed the highest identity (63%) with a β-lactamase of Sinorhizobium meliloti, an environmental bacterium. Hydrolysis studies demonstrated that purified BKC-1 not only hydrolyzed carbapenems but also penicillins, cephalosporins, and monobactams. However, the carbapenems were less efficiently hydrolyzed due to their very low kcat values (0.0016 to 0.031 s(-1)). In fact, oxacillin was the best substrate for BKC-1 (kcat /Km , 53,522.6 mM(-1) s(-1)). Here, we report a new class A carbapenemase, confirming the diversity and rapid evolution of β-lactamases in K. pneumoniae clinical isolates.

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesBrazilCarbapenemsCephalosporinsDrug Resistance, BacterialElectrophoresis, Gel, Pulsed-FieldKlebsiella pneumoniaeMicrobial Sensitivity TestsMonobactamsPenicillinsSinorhizobium melilotiAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsCephalosporinsMonobactamsPenicillins

Identifiers

PMID26055384
PMCPMC4538461
OpenAlexW1776092547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.